Share Price and Basic Stock Data
Last Updated: December 9, 2025, 11:02 pm
| PEG Ratio | 0.05 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Garodia Chemical Ltd operates in the trading and distribution sector, with a current share price of ₹10.7 and a market capitalization of ₹7.68 Cr. The company has reported zero sales in the last several quarters, with figures consistently standing at ₹0.00 from September 2022 through September 2024. This lack of revenue generation highlights a significant challenge in operational performance. Additionally, the company has recorded expenses that have fluctuated but remained minimal, with the highest expense reported at ₹0.12 Cr in March 2025. Such trends indicate a stark contrast to standard industry practices, where companies typically generate consistent sales. As a result, Garodia’s business model may require substantial reevaluation to align with market expectations and improve revenue generation capabilities.
Profitability and Efficiency Metrics
Garodia Chemical Ltd’s profitability metrics reveal significant challenges. The company has reported negative operating profits across the board, with the most recent operating profit standing at -₹0.12 Cr for the year ending March 2025. The operating profit margin (OPM) remains unreported, reflecting ongoing operational inefficiencies. The return on equity (ROE) has not been disclosed, but the return on capital employed (ROCE) stood at an impressive 323%, primarily due to the absence of effective capital utilization. However, the net profit for the trailing twelve months (TTM) stood at ₹3.79 Cr, indicating a potential turnaround. The reported earnings per share (EPS) of ₹5.58 for September 2025 suggests a significant improvement, although it follows a history of negative EPS in prior periods. Overall, the company must address its operational inefficiencies to convert its positive net profit into sustainable profitability.
Balance Sheet Strength and Financial Ratios
Garodia Chemical Ltd’s balance sheet presents a complex picture. The company’s total borrowings stood at ₹0.76 Cr, indicating a conservative approach to leveraging, which is favorable in uncertain market conditions. However, the reserves have declined to -₹7.93 Cr, raising concerns about financial stability and the ability to fund future operations. The current ratio is notably high at 4.35, suggesting that the company has sufficient short-term assets to cover its liabilities, which is a positive indicator of liquidity. Nevertheless, the price-to-book value (P/BV) ratio of -2.04x indicates that the market values the company below its book value, reflecting investor skepticism. With a debt-to-equity ratio of -1.03, Garodia is in a precarious position with negative equity, which can be a red flag for potential investors and creditors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Garodia Chemical Ltd shows a stable but concerning distribution among stakeholders. Promoters hold a significant 51.79% stake, which provides a degree of control over company decisions. The government holds a 10.42% stake, while the public owns 37.79%, comprising 7,647 shareholders. This distribution indicates a relatively concentrated ownership structure, potentially leading to challenges in corporate governance and transparency. The stability in promoter holdings over time suggests a long-term commitment; however, the lack of foreign institutional investments (FIIs) and domestic institutional investments (DIIs) points to a lack of external confidence in the company’s prospects. The public’s ownership, while substantial, may not be enough to influence positive changes in operations or strategy, especially given the ongoing revenue challenges.
Outlook, Risks, and Final Insight
The outlook for Garodia Chemical Ltd is mixed, with potential for improvement tempered by significant risks. The positive net profit reported for September 2025 could signal a turnaround, but it is essential to assess whether this trend can be sustained. Key risks include the company’s persistent lack of revenue generation, ongoing negative reserves, and a reliance on a concentrated shareholding structure that may stifle innovation and responsiveness to market changes. If Garodia can successfully pivot its business model to generate consistent revenue and leverage its balance sheet effectively, it may regain investor confidence. However, failure to address operational inefficiencies and financial stability could lead to further declines in market perception and performance. Overall, the company’s future hinges on its ability to execute a strategic turnaround while navigating the inherent challenges of its current financial position.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Millennium Online Solutions (India) Ltd | 7.60 Cr. | 1.52 | 2.88/1.52 | 0.81 | 0.00 % | 4.61 % | 5.54 % | 1.00 | |
| Minal Industries Ltd | 55.2 Cr. | 2.88 | 5.59/2.60 | 36.8 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 11.3 Cr. | 12.8 | 17.8/11.7 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 5.23 Cr. | 57.5 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 147 Cr. | 47.1 | 54.5/10.2 | 164 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| Industry Average | 8,591.97 Cr | 151.60 | 85.24 | 120.60 | 0.43% | 15.22% | 8.81% | 7.62 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.01 | 0.01 | 0.02 | 0.05 | 0.01 | 0.04 | 0.03 | 0.01 | 0.11 | 0.05 | 0.12 | 0.06 | 0.04 |
| Operating Profit | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.11 | -0.05 | -0.12 | -0.06 | -0.04 |
| OPM % | |||||||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.11 | -0.05 | -0.12 | -0.06 | 4.02 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.11 | -0.05 | -0.12 | -0.06 | 4.02 |
| EPS in Rs | -0.01 | -0.01 | -0.03 | -0.07 | -0.01 | -0.06 | -0.04 | -0.01 | -0.15 | -0.07 | -0.17 | -0.08 | 5.58 |
Last Updated: January 8, 2026, 8:08 am
Below is a detailed analysis of the quarterly data for Garodia Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 0.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.06 Cr. (Jun 2025) to 0.04 Cr., marking a decrease of 0.02 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.04 Cr.. The value appears strong and on an upward trend. It has increased from -0.06 Cr. (Jun 2025) to -0.04 Cr., marking an increase of 0.02 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Other Income, as of Sep 2025, the value is 4.06 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 4.06 Cr., marking an increase of 4.06 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 4.02 Cr.. The value appears strong and on an upward trend. It has increased from -0.06 Cr. (Jun 2025) to 4.02 Cr., marking an increase of 4.08 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 4.02 Cr.. The value appears strong and on an upward trend. It has increased from -0.06 Cr. (Jun 2025) to 4.02 Cr., marking an increase of 4.08 Cr..
- For EPS in Rs, as of Sep 2025, the value is 5.58. The value appears strong and on an upward trend. It has increased from -0.08 (Jun 2025) to 5.58, marking an increase of 5.66.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.06 | 0.07 | 0.21 | 0.11 | 0.13 | 0.20 | 0.26 | 0.18 | 0.09 | 0.06 | 0.13 | 0.21 | 0.27 |
| Operating Profit | -0.06 | -0.07 | -0.21 | -0.11 | -0.13 | -0.20 | -0.26 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | -0.27 |
| OPM % | |||||||||||||
| Other Income | 0.00 | -1.67 | 6.14 | 0.00 | 3.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.18 | -1.85 | 5.82 | -0.22 | 3.32 | -0.20 | -0.68 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | 3.79 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.18 | -1.85 | 5.81 | -0.22 | 3.32 | -0.20 | -0.68 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | 3.79 |
| EPS in Rs | -0.25 | -2.57 | 8.07 | -0.31 | 4.61 | -0.28 | -0.94 | -0.25 | -0.14 | -0.08 | -0.18 | -0.29 | 5.26 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -927.78% | 414.05% | -103.79% | 1609.09% | -106.02% | -240.00% | 73.53% | 44.44% | 40.00% | -116.67% | -61.54% |
| Change in YoY Net Profit Growth (%) | 0.00% | 1341.83% | -517.84% | 1712.88% | -1715.12% | -133.98% | 313.53% | -29.08% | -4.44% | -156.67% | 55.13% |
Garodia Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 11% |
| 3 Years: | % |
| TTM: | -178% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 3% |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 3:31 pm
Balance Sheet
Last Updated: January 7, 2026, 5:31 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
| Reserves | -17.41 | -19.26 | -13.44 | -13.66 | -10.34 | -10.54 | -11.22 | -11.40 | -11.50 | -11.56 | -11.69 | -11.90 | -7.93 |
| Borrowings | 6.03 | 8.37 | 7.22 | 7.32 | 3.80 | 3.43 | 4.08 | 4.18 | 4.31 | 4.34 | 4.50 | 4.82 | 0.76 |
| Other Liabilities | 6.64 | 6.03 | 0.87 | 0.48 | 0.01 | 0.02 | 0.11 | 0.13 | 0.10 | 0.08 | 0.10 | 0.02 | 0.06 |
| Total Liabilities | 2.46 | 2.34 | 1.85 | 1.34 | 0.67 | 0.11 | 0.17 | 0.11 | 0.11 | 0.06 | 0.11 | 0.14 | 0.09 |
| Fixed Assets | 1.59 | 1.48 | 1.37 | 1.26 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Other Assets | 0.87 | 0.86 | 0.48 | 0.08 | 0.67 | 0.11 | 0.17 | 0.11 | 0.11 | 0.06 | 0.11 | 0.14 | 0.09 |
| Total Assets | 2.46 | 2.34 | 1.85 | 1.34 | 0.67 | 0.11 | 0.17 | 0.11 | 0.11 | 0.06 | 0.11 | 0.14 | 0.09 |
Below is a detailed analysis of the balance sheet data for Garodia Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.20 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.20 Cr..
- For Reserves, as of Sep 2025, the value is -7.93 Cr.. The value appears to be improving (becoming less negative). It has improved from -11.90 Cr. (Mar 2025) to -7.93 Cr., marking an improvement of 3.97 Cr..
- For Borrowings, as of Sep 2025, the value is 0.76 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 4.82 Cr. (Mar 2025) to 0.76 Cr., marking a decrease of 4.06 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.02 Cr. (Mar 2025) to 0.06 Cr., marking an increase of 0.04 Cr..
- For Total Liabilities, as of Sep 2025, the value is 0.09 Cr.. The value appears to be improving (decreasing). It has decreased from 0.14 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.05 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 0.09 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.05 Cr..
- For Total Assets, as of Sep 2025, the value is 0.09 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.05 Cr..
However, the Borrowings (0.76 Cr.) are higher than the Reserves (-7.93 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -6.09 | -8.44 | -7.43 | -7.43 | -3.93 | -3.63 | -4.34 | -4.36 | -4.41 | -4.40 | -4.63 | -5.03 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | |||||||||||
| Inventory Days | 0.00 | |||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | |||||||||||
| Working Capital Days | -1,825.00 | |||||||||||
| ROCE % | -23.91% | 40.79% | -53.33% | -346.67% | -900.00% | -323.08% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.29 | -0.18 | -0.08 | -0.14 | -0.24 |
| Diluted EPS (Rs.) | -0.29 | -0.18 | -0.08 | -0.14 | -0.24 |
| Cash EPS (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -6.52 | -6.24 | -6.05 | -5.97 | -5.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -6.52 | -6.24 | -6.05 | -5.97 | -5.83 |
| PBDIT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| PBIT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| PBT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Net Profit / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Return on Capital Employeed (%) | -170.81 | -853.17 | 342.31 | -1091.55 | 1173.56 |
| Return On Assets (%) | -148.86 | -203.41 | -56.42 | -96.16 | -164.79 |
| Long Term Debt / Equity (X) | -1.03 | -1.00 | -0.99 | -1.00 | -0.99 |
| Total Debt / Equity (X) | -1.03 | -1.00 | -0.99 | -1.00 | -0.99 |
| Current Ratio (X) | 4.35 | 0.06 | 0.36 | 0.46 | 0.37 |
| Quick Ratio (X) | 4.35 | 0.06 | 0.36 | 0.46 | 0.37 |
| Enterprise Value (Cr.) | 14.36 | 11.41 | 11.18 | 8.12 | 8.01 |
| EV / EBITDA (X) | -69.17 | -87.07 | -186.40 | -79.12 | -45.66 |
| Price / BV (X) | -2.04 | -1.54 | -1.57 | -0.88 | -0.91 |
| EarningsYield | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 |
After reviewing the key financial ratios for Garodia Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 5. It has decreased from -0.18 (Mar 24) to -0.29, marking a decrease of 0.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 5. It has decreased from -0.18 (Mar 24) to -0.29, marking a decrease of 0.11.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 3. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.52. It has decreased from -6.24 (Mar 24) to -6.52, marking a decrease of 0.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.52. It has decreased from -6.24 (Mar 24) to -6.52, marking a decrease of 0.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 2. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 0. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 0. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 2. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is -170.81. This value is below the healthy minimum of 10. It has increased from -853.17 (Mar 24) to -170.81, marking an increase of 682.36.
- For Return On Assets (%), as of Mar 25, the value is -148.86. This value is below the healthy minimum of 5. It has increased from -203.41 (Mar 24) to -148.86, marking an increase of 54.55.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -1.03. This value is below the healthy minimum of 0.2. It has decreased from -1.00 (Mar 24) to -1.03, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is -1.03. This value is within the healthy range. It has decreased from -1.00 (Mar 24) to -1.03, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 4.35. This value exceeds the healthy maximum of 3. It has increased from 0.06 (Mar 24) to 4.35, marking an increase of 4.29.
- For Quick Ratio (X), as of Mar 25, the value is 4.35. This value exceeds the healthy maximum of 2. It has increased from 0.06 (Mar 24) to 4.35, marking an increase of 4.29.
- For Enterprise Value (Cr.), as of Mar 25, the value is 14.36. It has increased from 11.41 (Mar 24) to 14.36, marking an increase of 2.95.
- For EV / EBITDA (X), as of Mar 25, the value is -69.17. This value is below the healthy minimum of 5. It has increased from -87.07 (Mar 24) to -69.17, marking an increase of 17.90.
- For Price / BV (X), as of Mar 25, the value is -2.04. This value is below the healthy minimum of 1. It has decreased from -1.54 (Mar 24) to -2.04, marking a decrease of 0.50.
- For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Garodia Chemical Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -170.81% (Industry Average ROCE: 15.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 8.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 2.03 (Industry average Stock P/E: 85.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -1.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 149/156, Garodia Shopping Centre, Garodia Nagar, Mumbai Maharashtra 400077 | gclshares@gmail.com www.gchem.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravindra Subhash Salunkhe | Chairperson & Managing Director |
| Mr. Vikram Ravindra Sabnis | Additional Non Exe.Non Ind.Director |
| Mr. Suraj Kodak | Addnl.Non Exe.Independent Director |
| Ms. Megha Brahmankar | Addnl.Non Exe.Independent Director |
| Mrs. Bhagyashri Nilesh Devrale | Addnl.Non Exe.Independent Director |
FAQ
What is the intrinsic value of Garodia Chemical Ltd?
Garodia Chemical Ltd's intrinsic value (as of 29 January 2026) is ₹0.36 which is 96.64% lower the current market price of ₹10.70, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹7.68 Cr. market cap, FY2025-2026 high/low of ₹13.4/6.01, reserves of ₹-7.93 Cr, and liabilities of ₹0.09 Cr.
What is the Market Cap of Garodia Chemical Ltd?
The Market Cap of Garodia Chemical Ltd is 7.68 Cr..
What is the current Stock Price of Garodia Chemical Ltd as on 29 January 2026?
The current stock price of Garodia Chemical Ltd as on 29 January 2026 is ₹10.7.
What is the High / Low of Garodia Chemical Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Garodia Chemical Ltd stocks is ₹13.4/6.01.
What is the Stock P/E of Garodia Chemical Ltd?
The Stock P/E of Garodia Chemical Ltd is 2.03.
What is the Book Value of Garodia Chemical Ltd?
The Book Value of Garodia Chemical Ltd is 1.01.
What is the Dividend Yield of Garodia Chemical Ltd?
The Dividend Yield of Garodia Chemical Ltd is 0.00 %.
What is the ROCE of Garodia Chemical Ltd?
The ROCE of Garodia Chemical Ltd is 323 %.
What is the ROE of Garodia Chemical Ltd?
The ROE of Garodia Chemical Ltd is %.
What is the Face Value of Garodia Chemical Ltd?
The Face Value of Garodia Chemical Ltd is 10.0.